2) Nonbiologic DMARDs
On the other hand, nonbiologic DMARDs are typically used as a first line of treatment for RA. These medications are designed to reduce inflammation and pain, slow the progression of joint damage, and reduce the risk of disability.
Commonly prescribed nonbiologic DMARDs include methotrexate, hydroxychloroquine, sulfasalazine, and leflunomide. While nonbiologic DMARDs are generally well tolerated, they can have severe side effects such as liver damage and bone marrow suppression.
Nonbiologic DMARDs are usually taken orally as first-line treatments for mild to moderate rheumatoid arthritis but can also be used in combination with biologic DMARDs for more severe cases.
Overall, both biologic and nonbiologic DMARDs can be effective treatments for RA. However, it is essential to work closely with your healthcare provider to determine the best course of treatment for your specific symptoms.